UnitedHealth Group Inc (UNH) : Acropolis Investment Management reduced its stake in UnitedHealth Group Inc by 4.21% during the most recent quarter end. The investment management company now holds a total of 23,033 shares of UnitedHealth Group Inc which is valued at $3,169,341 after selling 1,012 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on Oct 5, 2016.UnitedHealth Group Inc makes up approximately 0.59% of Acropolis Investment Management’s portfolio.
Other Hedge Funds, Including , Bnp Paribas Arbitrage Sa boosted its stake in UNH in the latest quarter, The investment management firm added 313,125 additional shares and now holds a total of 459,451 shares of UnitedHealth Group Inc which is valued at $63,220,458. UnitedHealth Group Inc makes up approx 0.26% of Bnp Paribas Arbitrage Sa’s portfolio.Eqis Capital Management reduced its stake in UNH by selling 2,220 shares or 26.91% in the most recent quarter. The Hedge Fund company now holds 6,031 shares of UNH which is valued at $829,866. UnitedHealth Group Inc makes up approx 0.05% of Eqis Capital Management’s portfolio.Washington Trust Bank reduced its stake in UNH by selling 413 shares or 1.41% in the most recent quarter. The Hedge Fund company now holds 28,906 shares of UNH which is valued at $3,977,466. UnitedHealth Group Inc makes up approx 0.95% of Washington Trust Bank’s portfolio.West Oak Capital boosted its stake in UNH in the latest quarter, The investment management firm added 50 additional shares and now holds a total of 130 shares of UnitedHealth Group Inc which is valued at $17,888. UnitedHealth Group Inc makes up approx 0.01% of West Oak Capital’s portfolio.
UnitedHealth Group Inc closed down -0.33 points or -0.24% at $138.16 with 24,52,575 shares getting traded on Tuesday. Post opening the session at $138.69, the shares hit an intraday low of $137.16 and an intraday high of $139.3599 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.